VITAL Study
Study / Research
A large, 5-year randomized control trial where individuals given a low dose of omega-3 (Lovaza, EPA and DHA) showed a 30% lower heart attack risk in secondary outcomes.
Mentioned in 1 video
A large, 5-year randomized control trial where individuals given a low dose of omega-3 (Lovaza, EPA and DHA) showed a 30% lower heart attack risk in secondary outcomes.